GlaxoSmithKline Q1 profit up nearly 3%; Stock down 3.13%

GlaxoSmithKline Consumer Healthcare (GSK) has reported nearly 3% rise in standalone net profit for the first quarter (Q1) ended on June 30, 2016.

The net profit of GlaxoSmithKline Consumer Healthcare for the April-June quarter of the fiscal year 2016-17 (FY17) grew by 2.92% to Rs 16,061 lakh as against Rs 15,605 lakh in the corresponding quarter of previous fiscal, cited the company in a filing to the Bombay Stock Exchange (BSE) on Friday.

Its total income from operations during Q1 FY17 rose up by 1.36% to Rs 105,938 lakh as compared to Rs 107,395 lakh in Q1 FY16.

The company's total expenses during the period under review fell down by 2.01% to Rs 87,053 lakh as against Rs 88,836 lakh in the same period of last fiscal.

At 14:30 hours, on Friday, the stock of GlaxoSmithKline Consumer Healthcare (GSK) was trading down 3.13% or Rs 198.60 at Rs 6,156.00 on the BSE. 

See LIVE updates of stock price of GlaxoSmithKline Consumer Healthcare here-